Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Sale20 Feb 2026CME Group IncCME:NSQMartin J. GepsmanIndependent Director300305.90
USD
91.77k USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer3602.88
USD
1.04k USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer182.88
USD
52.00 USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer1802.88
USD
518.00 USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer1802.88
USD
518.00 USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer2962.88
USD
852.00 USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer182.88
USD
52.00 USD
Purchase19 Feb 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer822.88
USD
236.00 USD
Purchase19 Feb 2026USA Compression Partners LPUSAC:NYQBradford D. WhitehurstDirector10,00026.75
USD
267.50k USD
Purchase19 Feb 2026American Assets Trust IncAAT:NYQErnest S. RadyExecutive Chairman of the Board57,89818.83
USD
1.09m USD
Sale19 Feb 2026Tri Pointe Homes Inc (Delaware)TPH:NYQSteven J. GilbertChairman of the Board50,00046.33
USD
2.32m USD
Purchase19 Feb 2026Conduent IncCNDT:NSQHarshavardhan V. AgadiDirector and Chief Executive Officer110,0001.41
USD
155.32k USD
Sale19 Feb 2026Viant Technology IncDSP:NSQTim VanderhookChairman of the Board; Chief Executive Officer of the Company and Viant Technology LLC3,2799.17
USD
30.07k USD
Sale19 Feb 2026Viant Technology IncDSP:NSQChris VanderhookDirector; Chief Operating Officer of Company and Viant Technology LLC3,2799.17
USD
30.07k USD
Sale19 Feb 2026Recursion Pharmaceuticals IncRXRX:NSQChristopher GibsonChief Executive Officer, Director and President40,0003.46
USD
138.40k USD
21310 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.